Choosing the wrong UV curing tool for an assembly process does not just slow things down — it can leave adhesive under-cured at the edges, damage heat-sensitive components, or force workarounds that add time and cost. The fundamental decision in UV LED curing system selection starts here: flood lamp or spot lamp? What Each System Does A UV LED flood lamp illuminates a broad, relatively uniform area from a fixed distance. The light source is a dense array of UV LEDs spread across a planar or curved surface, designed to deliver consistent irradiance over an area that may range from a few square centimeters to several hundred square centimeters. Flood lamps are mounted above or beside a conveyor, a rotary table, or a static fixture, and they cure everything within their footprint simultaneously. A UV LED spot lamp concentrates its output through a light guide — typically a liquid-filled flexible tube or a fiber optic bundle — and delivers a focused beam to a small, defined area. The cure head may be handheld, mounted in a fixture, or attached to a robotic arm. Spot lamps are designed for selective, localized curing rather than broad-area exposure. The Core Trade-Off: Area vs. Precision The decision between flood and spot curing comes down to the geometry of the adhesive bond relative to the rest of the assembly. If the adhesive layer covers a large, accessible surface — a gasket, a display panel bond line, a filter assembly — a flood lamp cures the entire area in a single exposure. Cycle time is short, no repositioning is required, and uniformity across the bond area is inherent to the system design. If the adhesive is applied to a small, specific location — a lens seat, a wire strain relief, a sensor port — and especially if surrounding components are heat-sensitive, optically active, or must not receive UV exposure, a spot lamp is the appropriate tool. It delivers high irradiance to a precise location without illuminating adjacent areas. When Spot Lamps Are the Right Answer Several process characteristics point toward a spot lamp selection: Small bond areas. When adhesive is applied in volumes under a few cubic millimeters, or in diameters under approximately 10 mm, a spot lamp's concentrated output matches the cure area without wasting energy on surrounding substrate. Mixed-material assemblies. Assemblies combining UV-transparent and UV-opaque materials often require curing through a specific window or aperture. Spot lamps can be aimed through openings that a flood lamp cannot access uniformly. Sequential or selective curing. Some processes require curing individual joints one at a time — either because the assembly is built up progressively or because each bond position must be cured before the next component is placed. A spot lamp operated on a timer or controlled by a process signal handles this naturally. Thermal sensitivity. Even though UV LEDs produce less heat than mercury arc lamps, a high-power flood lamp operating for extended periods over a small assembly can raise substrate temperatures. A spot lamp,…

Every second of unnecessary cure time on a production line is money left on the table — and UV LED spot lamps exist specifically to eliminate that waste. These compact, high-intensity curing tools have reshaped how manufacturers bond, seal, and coat precision assemblies, replacing slower and more energy-intensive lamp technologies with a system that delivers targeted ultraviolet energy on demand. Defining the UV LED Spot Lamp A UV LED spot lamp is a curing instrument that concentrates high-intensity ultraviolet light onto a small, defined area. Unlike flood curing systems that illuminate broad surfaces, spot lamps are designed for localized applications — bonding a lens into a housing, tacking a component before full cure, or sealing a small port on a medical device. The "spot" refers not to a fixed geometry but to a concentrated beam, typically delivered through a light guide that terminates at or near the work surface. The LED in the name distinguishes this technology from earlier UV sources. Mercury arc lamps and metal halide bulbs generate ultraviolet light through gas discharge — an inherently broad-spectrum, heat-intensive process. UV LEDs, by contrast, emit light through semiconductor electroluminescence at discrete, well-defined wavelengths. This precision changes nearly everything about how curing systems are designed and operated. The Light Source: UV LEDs At the heart of a UV LED spot lamp is an array of high-power LED chips mounted on a thermally managed substrate. When electrical current passes through the semiconductor junction, electrons recombine with electron holes and release energy as photons. The wavelength of those photons is determined by the bandgap energy of the semiconductor material — a physical property that can be engineered during chip fabrication. UV LEDs used in curing systems typically emit at wavelengths between 365 nm and 405 nm, corresponding to the UVA range of the electromagnetic spectrum. Different formulations of UV-curable adhesives, coatings, and resins are optimized for specific wavelengths, so matching the lamp's emission peak to the photoinitiator's absorption peak is a key design consideration. How the Optical System Works Raw LED output, even from a tightly grouped array, radiates in multiple directions. A spot lamp system uses optical components to gather, collimate, or focus that output and deliver it efficiently to the target. The most common delivery mechanism is a light guide — either a liquid-filled flexible tube or a bundle of optical fibers — that channels light from the LED array to a handheld or fixture-mounted curing head. At the output end of the light guide, a focusing lens or collimating optic shapes the beam. The resulting spot size at the work surface depends on the light guide's numerical aperture, the lens geometry, and the working distance between the curing head and the substrate. A well-designed optical system maintains high irradiance — the intensity of UV energy per unit area — at the cure point, even when the cure head is held a few millimeters away from the part. Triggering and Control UV LED spot lamps are not continuous-on devices during production.…

Outgassing — the emission of volatile chemical species from a cured adhesive into the surrounding environment — is a concern that engineers sometimes overlook when specifying epoxy for enclosed medical device assemblies. The visible properties of the cured adhesive look right: it is hard, non-tacky, correctly colored, and dimensionally stable. But invisible to visual inspection, volatile compounds continue to desorb from the cured polymer network for hours, days, or weeks after cure, filling the enclosed space with trace quantities of organic vapors and water vapor. In open assemblies ventilated to ambient air, these vapors dissipate harmlessly. In enclosed assemblies — sealed housings, hermetically packaged components, confined spaces with optical elements or sensitive sensors — the accumulated volatiles cause corrosion, contamination, fogging, or biological effects that standard adhesive property specifications do not predict. What Outgasses from Cured Epoxy The volatile species that emit from cured epoxy after cure include: residual unreacted monomers and hardener components that did not fully react during cure, diluents and plasticizers incorporated in the formulation, reaction byproducts generated during the cure chemistry, antioxidants and stabilizers that are volatile at elevated temperatures, and water absorbed from the environment during or after cure. Residual monomer outgassing is proportional to the degree of cure — the fraction of reactive groups that completed the crosslinking reaction. Fully cured adhesive (95 percent or greater conversion) has much lower residual monomer content than partially cured adhesive. Post-cure at elevated temperature is the most effective way to reduce residual monomer outgassing: the additional heat drives the cure reaction further toward completion, consuming the reactive species that would otherwise outgas in service. Diluents — low-molecular-weight chemicals added to reduce adhesive viscosity for application — are often the largest contributors to outgassing if they do not fully react into the network. Reactive diluents (those with epoxide or amine groups that participate in the crosslinking reaction) become part of the cured network and do not outgas. Non-reactive diluents remain mobile within the network and continue to desorb throughout the adhesive's service life. Water vapor is a significant outgassing component for any epoxy stored or processed in a humid environment. Absorbed moisture in the adhesive at the time of cure produces bubbles in thick sections (if the cure is too fast), remains in the cured network, and releases over time. Low-humidity storage of the adhesive before use and a controlled bonding environment minimizes absorbed moisture entering the product. Why Outgassing Matters in Enclosed Medical Device Assemblies In sealed electronic packaging inside medical devices — ASIC packages, pressure sensor assemblies, optical module enclosures — volatile organic compounds from adhesive outgassing accumulate in the sealed gas volume. At sufficient concentrations, these vapors condense on cold surfaces, depositing organic films that contaminate contact surfaces, increase contact resistance, or block optical paths. Optical fogging is a visible failure mode from adhesive outgassing in sealed optical assemblies. Volatile adhesive components condense on the cooler optical surfaces — lenses, windows, detector surfaces — and deposit a thin film that scatters and absorbs light, reducing…

Pressure sensors in medical fluid-handling devices — infusion pumps, dialysis machines, ventilators, anesthesia delivery systems, and patient monitoring systems — must respond accurately to the pressure of the fluid they monitor while being protected from direct fluid contact that would cause corrosion, contamination, or biologically problematic material transfer to the patient fluid. The adhesive encapsulant around the pressure sensor element is the barrier that separates the electronic sensing die from the process fluid, and it must satisfy three simultaneous requirements that are often in tension: it must transmit the pressure signal accurately (compliance requirement), protect the sensor from chemical and moisture attack (barrier requirement), and not transfer harmful extractables to the patient fluid (biocompatibility requirement). Selecting and applying medical-grade epoxy for pressure sensor encapsulation in fluid-handling medical devices requires understanding how these requirements interact and how the encapsulant design addresses each. The Pressure Transmission Requirement Pressure sensors in medical applications measure gauge pressure of fluid — the pressure relative to atmospheric reference — by deflecting a thin diaphragm that generates a strain signal proportional to the applied pressure. The sensing element is isolated from the process fluid either by the diaphragm itself (if the fluid is compatible with silicon or stainless steel) or by a secondary diaphragm and oil-filled pressure transfer cavity. Where adhesive encapsulant is in contact with the primary diaphragm or the secondary diaphragm on the fluid side, the encapsulant modulus affects the pressure measurement. A very rigid encapsulant constrains the diaphragm deflection, reducing the sensor's sensitivity. A very soft encapsulant provides inadequate mechanical support and may introduce pressure measurement error from compliance of the encapsulant itself. Medical epoxy encapsulants for pressure sensor applications are formulated with modulus values in a specific range — typically 1 to 5 GPa — that provides adequate mechanical support without significantly constraining diaphragm deflection. Some sensor designs use the encapsulant only for peripheral support and leave the diaphragm area open to fluid or gas; in these configurations, the encapsulant modulus does not directly affect sensitivity but must still provide adequate structural retention of the sensor package. Thermal expansion of the encapsulant affects the zero offset of the pressure measurement through temperature. As temperature changes, the encapsulant expands or contracts, applying a parasitic stress to the diaphragm that the sensor reads as pressure even in the absence of applied fluid pressure. Low-CTE encapsulant formulations minimize this thermal zero shift. The CTE of the encapsulant should be matched as closely as possible to the CTE of the sensor package substrate (typically stainless steel or ceramic) to minimize differential thermal stress. Barrier Properties Against Fluid Ingress The encapsulant's barrier function protects the sensor electronic components from moisture and process fluid ingress. Moisture ingress causes corrosion of bond wire, die metallization, and lead frame materials; electrolytic leakage between high-impedance circuit nodes; and swelling of the epoxy package that applies stress to the die and causes mechanical sensitivity drift. Water vapor transmission through the cured epoxy is the key barrier property parameter. Standard medical-grade epoxy has water…

Ethylene oxide (EtO) sterilization remains one of the most widely used methods for terminal sterilization of single-use medical devices — particularly those with complex geometry, multiple materials, electronics, or optical components that cannot withstand the temperatures of steam autoclave or the radiation doses of gamma sterilization. The process exposes packaged devices to ethylene oxide gas, typically at 30°C to 60°C and relative humidity of 40 to 80 percent, for a cycle time of several hours, followed by an extended aeration period to remove residual EtO and its reaction byproducts. For device engineers concerned with adhesive bond integrity, EtO sterilization presents a different set of concerns than heat-based methods: the primary effects are chemical sorption and potential chemical reactivity, not thermal degradation. How EtO Interacts with Epoxy Adhesives Ethylene oxide is a small, reactive molecule (MW 44 g/mol) with significant affinity for organic polymer matrices. At the temperature and humidity conditions of EtO sterilization, EtO diffuses into the epoxy adhesive network, absorbing into the free volume of the cured polymer. The rate of absorption depends on the temperature, the EtO concentration, and the diffusion characteristics of the specific adhesive formulation. EtO in the absorbed state within the cured epoxy does not typically react with the fully crosslinked epoxy backbone at the concentrations and temperatures of sterilization. The concern is not chemical degradation of the adhesive network but rather two secondary effects: residual EtO content in the adhesive after aeration, and EtO reaction with specific functional groups present in the cured adhesive. Residual EtO and its hydrolysis products — ethylene glycol and ethylene chlorohydrin (in the presence of chloride from PVC or cleaning solutions) — are the regulated species in EtO-sterilized devices. ISO 10993-7 establishes maximum allowable residual levels: for general medical devices, 4 mg of EtO per device and 9 mg of ethylene chlorohydrin per device as 24-hour acute exposure limits, with lower limits for specific contact categories and for chronic exposure scenarios. The adhesive contributes to the device's total residual burden based on its volume and its diffusion characteristics. Thicker adhesive sections, or formulations with high EtO uptake, take longer to degas to acceptable residual levels during aeration. Understanding the adhesive's EtO sorption and desorption profile is necessary for validating that the aeration cycle achieves the required residual level. Effect on Mechanical Bond Properties The direct effect of EtO sterilization on the mechanical properties of fully cured medical-grade epoxy bonds is generally modest. At 40°C to 60°C — the sterilization temperature range — the adhesive is well below its Tg (which for medical-grade formulations is 120°C or above), so it remains in the glassy state throughout the cycle. Thermal softening is not a concern at EtO process temperatures. Short-term moisture absorption during the humidified EtO cycle plasticizes the adhesive slightly — reduced modulus and slightly reduced tensile strength — but this effect is temporary and reverses during aeration as moisture desorbs. For adhesive joints where the substrates are moisture-sensitive (some polymer substrates absorb moisture and soften their surface), the moisture…

Selecting a medical-grade epoxy adhesive and demonstrating that it performs adequately in the intended application are two separate activities, and both are required for FDA submissions for devices where adhesive bonding is a critical assembly method. Selection based on supplier data sheets establishes that the material has the right properties in general; qualification testing on the specific joint design, substrate combination, and environmental exposure of the actual device establishes that the specific implementation works. Building the documentation that connects these two activities into a coherent, FDA-ready package requires understanding what types of evidence the agency expects to see, how that evidence is organized, and where the gaps in supplier-provided data require device-level testing to fill. What FDA Expects for Material and Process Documentation FDA's technical requirements for device regulatory submissions do not specify exactly what tests must be run for adhesive bonds — they require that the manufacturer demonstrate the device is safe and effective through "valid scientific evidence." For structural adhesive bonds, valid scientific evidence consists of test data showing that the bond meets the design requirements under the conditions the device will actually encounter — not just at ambient conditions with fresh material. The Design History File (DHF) for the device must document: the design requirement for the bond (minimum strength, maximum allowable displacement, required service life), the rationale for selecting the adhesive (why this material meets the requirement), the testing performed to verify the design, and the results confirming that the design requirements are met. Each element must be documented and cross-referenced so that a reviewer can follow the logical chain from requirement to evidence. For 510(k) submissions, the device description section includes materials of construction. The submission should reference the adhesive by product name and indicate where documentation of its safety and performance can be found — typically in the design verification testing section and the biocompatibility section. For PMAs, the evidence requirements are more detailed, and design verification testing results may need to be summarized in the submission rather than simply referenced. Design Verification Testing for Adhesive Bonds Design verification testing for adhesive bonds confirms that the joint design meets the design requirements under specified conditions. The test matrix should include: Mechanical strength testing at ambient conditions: Lap shear strength (ASTM D1002 or ISO 4587) on test specimens prepared with the production surface preparation, production adhesive, production cure schedule, and the substrate materials used in the device. This establishes the baseline strength before environmental conditioning. Mechanical strength after environmental conditioning: The same specimens or companion specimens tested after conditioning that simulates device service conditions — autoclave cycling for reusable devices (typically 200 to 500 cycles at the worst-case sterilization temperature), chemical soak in relevant cleaning agents, humidity aging, or temperature cycling as applicable. The retention of required strength after conditioning is the critical result. Mechanical strength over the device design life: For devices with long service lives (5 to 10 years), the conditioning program must demonstrate performance through the full design life, either by direct…

PEEK (polyether ether ketone) and polysulfone are the high-performance engineering polymers of choice for medical device components that must survive autoclave sterilization, maintain dimensional stability under load, and resist the chemical environments of clinical use. Their combination of mechanical strength, temperature resistance, and biocompatibility makes them the preferred materials for reusable surgical instrument components, endoscope housings, fluid manifolds in diagnostic instruments, and structural elements in powered surgical devices. Bonding these materials with epoxy adhesive requires surface preparation that overcomes the inherently low surface energy of both polymers — and epoxy adhesive selection that matches the service temperature and sterilization method of the specific device. Why High-Performance Polymers Are Difficult to Bond PEEK and polysulfone both have surface energies that make standard adhesive wetting difficult without surface activation. The molecular structure of PEEK — alternating aromatic rings and ether/ketone linkages — presents a relatively inert surface to adhesive chemistry. The surface energy of untreated PEEK is approximately 40 to 45 mN/m — lower than metal but higher than PTFE, placing it in a challenging intermediate zone where some adhesives wet it incompletely and adhesion is variable. Polysulfone has similar surface characteristics. Its surface energy without treatment is approximately 40 to 44 mN/m, and the sulfone groups in the backbone provide limited chemical reactivity for adhesive bonding without activation. Both materials are also semi-crystalline or amorphous high-Tg polymers that are resistant to solvent-based surface treatments. Solvents that would etch or swell lower-performance polymers — and thereby increase surface roughness and bonding sites — have minimal effect on PEEK and polysulfone at room temperature. The practical result is that adhesive applied to untreated PEEK or polysulfone surfaces often achieves only 30 to 60 percent of the adhesion strength achieved with properly treated surfaces. The failure mode is adhesive failure at the polymer surface — the adhesive detaches cleanly from the PEEK or polysulfone, indicating that chemical bonding to the polymer surface was not achieved. Surface Activation Methods for PEEK Plasma treatment is the most effective and most cleanly applicable surface activation method for PEEK in a medical device manufacturing environment. Oxygen plasma or air plasma at low pressure creates free radical sites on the PEEK surface by cleaving the carbon-oxygen and carbon-carbon bonds at the surface, followed by oxidation that introduces carboxylic acid, carbonyl, and hydroxyl functional groups. These polar groups dramatically increase surface energy — to above 60 mN/m — and provide reactive sites for covalent bonding with epoxy adhesive. Plasma activation effect is temporary: the high surface energy created by plasma treatment decays over time as the activated surface returns to a lower-energy state through surface rearrangement. The time window for bonding after plasma treatment is typically 30 minutes to 4 hours for PEEK, depending on storage conditions — bonding must occur within this window for the full activation benefit. Atmospheric pressure plasma (corona treatment) provides a similar activation effect without requiring a vacuum chamber, making it more easily integrated into production assembly lines. Handheld atmospheric plasma devices allow spot treatment…

Optical sensors in diagnostic medical devices — photodetectors, light emitters, optical fibers, lenses, and beam splitters — must be positioned with micrometer-level precision and held there through the service life of the instrument. The adhesive that bonds these components is not simply a mechanical fastener; it is a functional element in the optical path or the optical structure, and its properties — optical transmission, refractive index, UV stability, dimensional stability under temperature change — determine whether the sensor performs within specification at every clinical measurement, not just at initial calibration. Medical-grade epoxy for optical sensor assembly must satisfy the biological evaluation requirements of a medical device material while also meeting the optical and mechanical requirements that instrument performance demands. Why Optical Adhesive Selection Is Different from Structural Bonding In structural bonding, the adhesive fills a gap and transmits load — its optical properties are irrelevant. In optical sensor assembly, the adhesive may be in or adjacent to the optical path, where its transmission, refractive index, and fluorescence affect the signal the detector receives. For applications where the adhesive bonds components outside the optical path — attaching a photodetector mount to a circuit board, fixing a lens barrel to a housing wall — the optical properties of the adhesive are not relevant, and the selection proceeds on mechanical and biocompatibility criteria alone. For applications where the adhesive is optically in-line — bonding a coverslip over a detector, securing a fiber optic in a ferrule, assembling a flow cell with adhesive at the optical interface — the adhesive optical properties are as critical as its mechanical properties. Transmission at the operating wavelength, refractive index match to adjacent optical materials, autofluorescence at the excitation wavelength used in fluorescence-based assays, and UV stability over the instrument's service life all determine optical performance. Optical Transmission and Wavelength Range Diagnostic instruments use wavelengths spanning ultraviolet (250 to 380 nm for spectrophotometric and fluorescence detection), visible (380 to 750 nm for colorimetric detection), and near-infrared (750 to 1100 nm for tissue oximetry, near-IR spectroscopy). The adhesive must transmit at the operating wavelength with low absorption and low scattering. Standard bisphenol-A epoxy adhesives absorb strongly below approximately 380 nm — the aromatic chromophores in the backbone absorb UV radiation, creating a cut-on edge that blocks ultraviolet transmission. For UV-range diagnostic applications (DNA quantification, protein assay, drug concentration measurement), standard epoxy is optically unsuitable at the bond interface. Aliphatic epoxy formulations — using cycloaliphatic resins without aromatic groups — have UV transmission to below 300 nm and are appropriate for UV optical interfaces. In the visible and near-infrared range, standard medical-grade epoxy has good transmission — above 90 percent per mm path length for most formulations after full cure. Yellowing from incomplete cure, UV exposure, or thermal aging reduces transmission in the blue end of the visible spectrum over time. For fluorescence-based diagnostic instruments operating at typical excitation wavelengths (488 nm for green fluorophores, 532 nm for red), adhesive autofluorescence must be characterized. Some epoxy formulations contain fluorescent impurities…

Manufacturing engineers designing bonding processes for medical device assembly lines face the choice between UV-cure and heat-cure epoxy systems early in process development, and the choice has consequences that extend through the validation program, the production equipment investment, the quality control procedures, and the regulatory documentation. Each cure mechanism has genuine advantages for specific applications and genuine limitations that make it inappropriate for others. The decision is rarely about which technology is generally superior — it is about which technology's characteristics best match the specific assembly geometry, substrate materials, production volume, quality documentation requirements, and device regulatory category of the application. What UV-Cure Epoxy Does Well UV-cure adhesives cure rapidly — seconds to minutes under appropriate UV or visible light intensity — which provides two production advantages that heat-cure systems cannot match. On-demand cure means the adhesive does not cure until light is applied. The device can be dispensed, positioned, aligned, and inspected before cure is initiated. If the component position is wrong, it can be corrected by sliding it before cure. This rework capability before cure is valuable for assemblies requiring precise alignment — optical components, precision sensor mounts, small connector bodies — where heat-cure systems begin curing as soon as temperature is applied and leave less time for adjustment. Throughput: A 10-second UV cure cycle allows high production throughput without long oven queues. For medical device assembly with hundreds to thousands of units per day, the throughput difference between a 10-second UV cycle and a 60-minute oven cycle is substantial — UV cure allows inline production flow; heat cure requires oven batch management. UV-cure epoxy is also well-suited to assemblies where heat would damage adjacent components or distort the assembly geometry. Optical elements near polymers with lower softening temperatures, pre-assembled battery packs, and fragile sensor elements that cannot withstand even 80°C can be bonded with UV-cure adhesive without thermal risk. The limitation is geometry: UV cure requires light to reach the adhesive. If any portion of the bond area is shadowed — under an opaque component body, in a deep groove, or between two UV-opaque substrates — that portion does not cure. Shadow zone adhesive remains liquid or partially cured, which is a structural and biocompatibility failure (uncured epoxy has much higher extractable chemistry than fully cured material). For applications with complete UV access to the bond area, UV-cure is appropriate. For applications with any shadow geometry, UV cure is not, and either requires supplemental heat cure or the use of a dual-cure formulation that combines UV and heat cure mechanisms. What Heat-Cure Epoxy Does Well Heat-cure epoxy — both single-component heat-activated systems and two-component systems with elevated-temperature post-cure — develops full cure properties reliably regardless of geometry. The cure occurs wherever the adhesive is present, whether in shadow zones, under opaque components, or in deep recesses. There are no accessibility requirements on the cure energy source. For medical device applications where the adhesive bonds components that create shadow zones — component-over-pad configurations, housing assemblies where the adhesive…

The quality system requirements that govern medical device manufacturing under ISO 13485 treat raw materials — including adhesives — not as commodities that are received and used, but as controlled inputs whose identity, condition, and traceability through the production process must be documented and maintained. For an epoxy adhesive used in device production, this means that every lot used in manufacturing must be verified to be within its shelf life, documented in the device history record (DHR), and traceable forward to the specific devices manufactured with that lot and backward to the certificate of analysis that confirms its tested properties. Shelf life management and traceability are not optional documentation practices — they are requirements that directly affect device lot disposition and regulatory compliance, and gaps in either can result in field actions if a material quality issue is identified after distribution. What Shelf Life Documentation Requires Shelf life for a two-component epoxy adhesive is the period during which the product, stored under specified conditions, maintains properties within the specification limits. At the end of shelf life, the adhesive may have advanced in partial cure, changed viscosity, precipitated or settled, or undergone chemical changes that alter its cure characteristics or final mechanical properties. The shelf life claim must be based on demonstrated data — stability testing of the product under the specified storage conditions for the full claimed shelf life period, with properties measured at intervals and confirmed to remain within specification. For a medical-grade epoxy with a 24-month ambient-temperature shelf life claim, the supplier must have conducted stability testing that confirms the product meets specification throughout 24 months of storage at the specified temperature range. In production, the manufacturer must verify that each received lot is within its stated shelf life before use. This is done by comparing the lot expiration date from the certificate of analysis against the date of planned use. A lot received with 6 months of shelf life remaining must be used or managed to ensure it is consumed before expiration. If a lot is received past its expiration date, or if a lot in storage expires before it is used, the material must be quarantined, removed from the approved inventory, and either returned to the supplier, retested against acceptance criteria with a new shelf life determination if testing is feasible, or scrapped. Using expired material in production — even material that appears visually unchanged — is a nonconformance under ISO 13485 and potentially a violation of device regulations if the device is distributed. Certificate of Analysis Content Requirements The certificate of analysis (CoA) from the adhesive supplier provides the documentation basis for the received lot. For a medical-grade epoxy used in ISO 13485-compliant production, the CoA must include: Product name and part number, clearly identifying the specific formulation. Lot number, unique to the manufacturing batch, traceable back to the supplier's manufacturing records. Manufacturing date and expiration date (or shelf life from manufacturing date), defining the usability window. Tested properties with results, specifications, and test methods…